These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9762878)

  • 1. Clinical outcomes of localized melanoma of the foot: a case-control study.
    Talley LI; Soong S; Harrison RA; McCarthy WH; Urist MM; Balch CM
    J Clin Epidemiol; 1998 Oct; 51(10):853-7. PubMed ID: 9762878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma of the Foot Is Associated With Advanced Disease and Poorer Survival.
    Adams BE; Peng PD; Williams ML
    J Foot Ankle Surg; 2018; 57(1):52-55. PubMed ID: 29037928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current management and prognosis of acral lentiginous melanoma.
    Wells KE; Reintgen DS; Cruse CW
    Ann Plast Surg; 1992 Jan; 28(1):100-3. PubMed ID: 1642394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plantar melanoma: is the prognosis always bad?
    Baumert J; Schmidt M; Kunte C; Volkenandt M; Ruzicka T; Berking C; Schmid-Wendtner MH
    Dermatol Surg; 2010 Aug; 36(8):1325-7. PubMed ID: 20584045
    [No Abstract]   [Full Text] [Related]  

  • 5. Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome.
    Sanlorenzo M; Osella-Abate S; Ribero S; Marenco F; Nardò T; Fierro MT; Novelli M; Cervetti O; Bernengo MG; Quaglino P
    Int J Dermatol; 2015 Sep; 54(9):1023-9. PubMed ID: 25660506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma of the foot.
    Barnes BC; Seigler HF; Saxby TS; Kocher MS; Harrelson JM
    J Bone Joint Surg Am; 1994 Jun; 76(6):892-8. PubMed ID: 8200896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does localized melanoma of the foot have a poorer prognosis than melanoma of the leg?
    Corona R
    Arch Dermatol; 1999 Dec; 135(12):1529. PubMed ID: 10606061
    [No Abstract]   [Full Text] [Related]  

  • 8. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot.
    Bennett DR; Wasson D; MacArthur JD; McMillen MA
    J Am Coll Surg; 1994 Sep; 179(3):279-84. PubMed ID: 8069422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of patients with primary pedal melanoma.
    Walsh SM; Fisher SG; Sage RA
    J Foot Ankle Surg; 2003; 42(4):193-8. PubMed ID: 12907929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
    Sheen YS; Liao YH; Lin MH; Chiu HC; Jee SH; Liau JY; Chang YL; Chu CY
    PLoS One; 2016; 11(1):e0147431. PubMed ID: 26796627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanoma of the foot and ankle.
    Fortin PT; Freiberg AA; Rees R; Sondak VK; Johnson TM
    J Bone Joint Surg Am; 1995 Sep; 77(9):1396-403. PubMed ID: 7673291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and outcomes of melanoma in acral location in Korean patients.
    Roh MR; Kim J; Chung KY
    Yonsei Med J; 2010 Jul; 51(4):562-8. PubMed ID: 20499423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma of the feet: misdiagnosed and misunderstood.
    Albreski D; Sloan SB
    Clin Dermatol; 2009; 27(6):556-63. PubMed ID: 19880043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
    Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
    Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with melanoma of the lower extremity decreases with distance from the trunk.
    Hsueh EC; Lucci A; Qi K; Morton DL
    Cancer; 1999 Jan; 85(2):383-8. PubMed ID: 10023706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous spectrum of acral melanoma: A clinicoprognostic study of 213 acral melanomas according to tumor site.
    Moon HR; Kang HJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
    J Am Acad Dermatol; 2018 Jan; 78(1):179-182.e3. PubMed ID: 29241776
    [No Abstract]   [Full Text] [Related]  

  • 20. A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models.
    Day CL; Lew RA; Mihm MC; Sober AJ; Harris MN; Kopf AW; Fitzpatrick TB; Harrist TJ; Golomb FM; Postel A; Hennessey P; Gumport SL; Raker JW; Malt RA; Cosimi AB; Wood WC; Roses DF; Gorstein F; Rigel D; Friedman RJ; Mintzis MM; Grier RW
    Ann Surg; 1982 Jan; 195(1):44-9. PubMed ID: 7055383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.